pubmed-article:10659049 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0001175 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0039215 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C2346689 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0332162 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C1550025 | lld:lifeskim |
pubmed-article:10659049 | lifeskim:mentions | umls-concept:C0449435 | lld:lifeskim |
pubmed-article:10659049 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:10659049 | pubmed:dateCreated | 2000-2-18 | lld:pubmed |
pubmed-article:10659049 | pubmed:abstractText | To identify factors associated with development of AIDS at high CD4+ cell levels a nested case-control study using data from the Multicenter AIDS Cohort Study (MACS) was conducted. HIV-1-infected men who developed AIDS with > or =300/mm3 CD4+ cells (AIDS men) were compared to men who had > or =300/mm3 of CD4+ cells, but remained AIDS free for at least 2 years. The AIDS men had higher plasma HIV-1 RNA levels (mean 10(5.02) vs. 10(4.42), p<0.01) and neopterin levels (mean 18.3 vs. 11.5 units/ml, p<0.05) before the AIDS diagnosis than did the AIDS-free men. A significantly higher proportion of the AIDS men reported genital herpes within the year prior to their initial AIDS diagnosis than did the AIDS-free men (21.9 vs. 4.4%, p<0.05). The higher viral load at relatively high CD4+ cell levels in men who subsequently developed AIDS within 6 months supports the hypothesis that elevated levels of HIV precede CD4+ decline and are the major factor in determining risk of AIDS even at high levels of CD4+ cell levels. | lld:pubmed |
pubmed-article:10659049 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10659049 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10659049 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10659049 | pubmed:language | eng | lld:pubmed |
pubmed-article:10659049 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10659049 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10659049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10659049 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10659049 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10659049 | pubmed:month | Jan | lld:pubmed |
pubmed-article:10659049 | pubmed:issn | 0889-2229 | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:DetelsRR | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:PhairJJ | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:VisscherB RBR | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:MargolickJ... | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:GiorgiJ VJV | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:RiddlerSS | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:KaplanA HAH | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:GangeSS | lld:pubmed |
pubmed-article:10659049 | pubmed:author | pubmed-author:HennesseyK... | lld:pubmed |
pubmed-article:10659049 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10659049 | pubmed:day | 20 | lld:pubmed |
pubmed-article:10659049 | pubmed:volume | 16 | lld:pubmed |
pubmed-article:10659049 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10659049 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10659049 | pubmed:pagination | 103-7 | lld:pubmed |
pubmed-article:10659049 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:meshHeading | pubmed-meshheading:10659049... | lld:pubmed |
pubmed-article:10659049 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10659049 | pubmed:articleTitle | AIDS onset at high CD4+ cell levels is associated with high HIV load. | lld:pubmed |
pubmed-article:10659049 | pubmed:affiliation | Los Angeles Center of the Multicenter AIDS Cohort Study, Department of Epidemiology, UCLA School of Public Health, California, USA. | lld:pubmed |
pubmed-article:10659049 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10659049 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:10659049 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10659049 | lld:pubmed |